在抑郁症中选择抗抑郁药治疗的机器学习.
Prehm I M Arnold1, Joost G E Janzing1, Arjen Hommersom2
1Department of Psychiatry, Radboudumc, Nijmegen, the Netherlands.
Drug discovery today
|June 26, 2024
概括
使用机器学习 (ML) 来个性化选择主要抑郁症的抗抑郁药物显示出希望,但目前临床价值有限. 未来的模型必须考虑实际应用的有效性以外的因素.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 计算医学是一种计算医学.
- 药物基因组学 药物基因组学
背景情况:
- 大型抑郁症的治疗通常依赖于试错抗抑郁药的选择.
- 需要个性化医疗方法来优化治疗结果.
- 机器学习 (ML) 为数据驱动的抗抑郁药物处方提供了潜力.
研究的目的:
- 审查当前关于机器学习在选择抗抑郁药物的应用的证据.
- 评估基于ML的抗抑郁药预测模型的临床实用性和局限性.
- 确定必要的因素,以加强在临床精神病学中ML的实际应用.
主要方法:
- 对抗抑郁药物选择中的机器学习应用现有文献的系统审查.
- 分析评估ML模型有效性和预测准确性的研究.
- 综合关于心理药理学ML当前状态和未来方向的发现.
主要成果:
- 目前的证据表明,机器学习在临床抗抑郁药物选择中的价值仍然有限.
- 现有的ML模型主要关注治疗有效性,忽视了其他关键的患者因素.
- 在将ML研究转化为常规临床实践方面,仍然存在重大挑战.
结论:
- 机器学习有可能对重大抑郁症的抗抑郁药物处方进行个性化.
- 当前ML模型的临床实用性受到其有限的范围和实际适用性的限制.
- 未来的开发应该纳入更广泛的患者特定因素,而不仅仅是有效性,以提高ML模型在现实环境中的实用性.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
215
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
215
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
363
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
363
Antidepressant Drugs: Overview
433
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
433
Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
Depression: Overview
237
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
237
Mania and Antimanic Drugs: Overview
163
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
163


